We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-16.02%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.06B
AUM Growth
-$137M
Cap. Flow
+$265M
Cap. Flow %
12.86%
Top 10 Hldgs %
24.21%
Holding
521
New
168
Increased
68
Reduced
54
Closed
173

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$55.4M
2
AMZN icon
Amazon
AMZN
+$42.6M
3
DAL icon
Delta Air Lines
DAL
+$38.5M
4
PYPL icon
PayPal
PYPL
+$37.8M
5
MHK icon
Mohawk Industries
MHK
+$36.6M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$44.8M
2
BBWI icon
Bath & Body Works
BBWI
+$43M
3
PSX icon
Phillips 66
PSX
+$26.6M
4
DIS icon
Walt Disney
DIS
+$26.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.86%
2 Technology 9.38%
3 Financials 8.53%
4 Communication Services 7.7%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFRM icon
251
CALL
Affirm
AFRM
$23.9B
$948K 0.05%
+52,500
New +$1.43M
CPUH
252
DELISTED
Compute Health Acquisition Corp.
CPUH
$945K 0.05%
96,380
– –
KRYS icon
253
Krystal Biotech
KRYS
$10.1B
$919K 0.04%
13,990
-17,869
-56% -$1.11M
COOL
254
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
$896K 0.04%
90,879
– –
MA icon
255
Mastercard
MA
$502B
$865K 0.04%
+2,742
New +$944K
NVSA
256
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$864K 0.04%
87,987
– –
GBT
257
DELISTED
Global Blood Therapeutics, Inc.
GBT
$856K 0.04%
26,780
-87,312
-77% -$2.56M
ANF icon
258
Abercrombie & Fitch
ANF
$4.42B
$808K 0.04%
47,734
-243,625
-84% -$6.72M
EXPR
259
DELISTED
Express, Inc.
EXPR
$788K 0.04%
+20,102
New +$1.21M
ACAD icon
260
CALL
Acadia Pharmaceuticals
ACAD
$4.43B
$760K 0.04%
+53,900
New +$1.01M
EWT icon
261
PUT
iShares MSCI Taiwan ETF
EWT
$9.86B
$756K 0.04%
+15,000
New +$835K
NXDR
262
Nextdoor Holdings
NXDR
$847M
$748K 0.04%
+226,115
New +$888K
TARS icon
263
Tarsus Pharmaceuticals
TARS
$2.58B
$742K 0.04%
50,826
+40,282
+382% +$605K
NBIX icon
264
Neurocrine Biosciences
NBIX
$16.8B
$739K 0.04%
+7,582
New +$700K
NVAX icon
265
Novavax
NVAX
$1.2B
$727K 0.04%
+14,137
New +$732K
XLB icon
266
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$720K 0.04%
19,568
-8,856
-31% -$371K
AMLP icon
267
Alerian MLP ETF
AMLP
$13B
$690K 0.03%
+20,025
New +$769K
NU icon
268
Nu Holdings
NU
$69.2B
$686K 0.03%
+183,443
New +$931K
SABR icon
269
PUT
Sabre
SABR
$731M
$669K 0.03%
+114,700
New +$958K
MYPS icon
270
PUT
PLAYSTUDIOS Inc
MYPS
$77.9M
$642K 0.03%
+150,000
New +$815K
XLY icon
271
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
$636K 0.03%
+9,258
New +$729K
BIG
272
CALL
DELISTED
Big Lots, Inc.
BIG
$629K 0.03%
+30,000
New +$882K
CTV
273
DELISTED
Innovid Corp.
CTV
$623K 0.03%
+375,000
New +$1.61M
TCDA
274
DELISTED
Tricida, Inc. Common Stock
TCDA
$611K 0.03%
63,154
-209,107
-77% -$1.99M
MSOS icon
275
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
$605K 0.03%
+58,500
New +$869K
9 10
11
12 13

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2022 Portfolio in Review

As of Q2 2022, J. Goldman & Co held 521 positions worth $2.06B, down 6.2% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

J. Goldman & Co deployed $265M of net new capital in Q2 2022, opening 168 new positions and adding to 68 existing holdings. Its largest new stake was Delta Air Lines: 1,010,148 shares worth $29.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bath & Body Works, an estimated $43M trimmed.

  • J. Goldman & Co's largest Q2 2022 buy was Delta Air Lines: 1,010,148 shares worth $29.3M.
  • J. Goldman & Co added most to Spotify in Q2 2022, an estimated $55.4M increase.
  • J. Goldman & Co's biggest Q2 2022 reduction was Bath & Body Works, cutting an estimated $43M.
  • J. Goldman & Co fully exited Cisco in Q2 2022, selling an estimated $44.8M.
  • J. Goldman & Co's ten largest holdings make up 24% of its $2.06B portfolio in Q2 2022.
  • J. Goldman & Co opened 168 new positions and closed 173 in Q2 2022.
  • J. Goldman & Co's portfolio value fell 6.2% quarter-over-quarter to $2.06B.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.